You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for generic pharmaceutical drug: tetracaine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


tetracaine hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Alcon Labs TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 208135 NDA Alcon Laboratories, Inc. 0065-0741-14 12 BLISTER PACK in 1 CARTON (0065-0741-14) / 1 BOTTLE, DROPPER in 1 BLISTER PACK / 4 mL in 1 BOTTLE, DROPPER 2016-11-02
Alcon Labs TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 208135 NDA A-S Medication Solutions 50090-2364-1 4 mL in 1 BOTTLE, DROPPER (50090-2364-1) 2016-11-02
Alcon Labs TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 208135 NDA REMEDYREPACK INC. 70518-4183-0 12 BOTTLE, DROPPER in 1 CARTON (70518-4183-0) / 4 mL in 1 BOTTLE, DROPPER (70518-4183-1) 2024-09-24
Bausch Lomb Ireland TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 210821 NDA Bausch Health US LLC 0187-0920-05 1 BOTTLE in 1 CARTON (0187-0920-05) / 5 mL in 1 BOTTLE 2019-06-27
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Tetracaine Hydrochloride

Last updated: August 2, 2025


Introduction

Tetracaine Hydrochloride is a local anesthetic widely used in ophthalmology, dentistry, and surgical procedures. Its effective numbing properties derive from its ability to block nerve conduction. As demand for this anesthetic persists across diverse medical disciplines, the supply chain's robustness becomes critical for healthcare providers and pharmaceutical manufacturers. This report examines leading suppliers of Tetracaine Hydrochloride, exploring manufacturing sources, regional distribution, and market dynamics.


Overview of Tetracaine Hydrochloride

Tetracaine Hydrochloride, chemically known as 2-(Dimethylamino)ethyl 4-(butylamino)benzoate hydrochloride, is characterized by high potency and moderate duration of action. Its primary applications include topical anesthesia for mucous membranes, ocular procedures, and infiltration anesthesia. Global markets demand consistent quality, regulatory compliance, and reliable supply chains from producers.


Major Suppliers and Manufacturers

1. Sigma-Aldrich (Merck Group)

Sigma-Aldrich, a subsidiary of Merck Group, is among the world's leading chemical and pharmaceutical suppliers, offering pharmaceutical-grade Tetracaine Hydrochloride. Their products are utilized mainly for research but also for manufacturing in pharmaceutical formulations. Sigma-Aldrich maintains rigorous quality standards, adhering to cGMP (current Good Manufacturing Practices), making their supply a benchmark in the industry [1].

2. Jiangsu Hengrui Medicine Co., Ltd.

A prominent Chinese pharmaceutical manufacturer, Jiangsu Hengrui specializes in anesthetics and local anesthetic agents, including Tetracaine Hydrochloride. Their production facilities operate under strict regulatory standards, and their supply serves both domestic and international markets. The company's strategic focus on research and production ensures a scalable and reliable supply chain [2].

3. Merck KGaA

In addition to Sigma-Aldrich, Merck KGaA itself manufactures Tetracaine Hydrochloride for clinical use and research purposes. Merck's global footprint allows for broad distribution, particularly across Europe and North America. Their commitment to high purity standards and regulatory compliance makes them a preferred supplier for large pharmaceutical firms [3].

4. Sandoz (Novartis)

Sandoz, a division of Novartis, supplies various generic pharmaceuticals, including local anesthetics like Tetracaine Hydrochloride. Sandoz's manufacturing facilities are certified by major regulatory bodies, aligning with global quality standards. Their extensive distribution channels ensure availability across multiple markets [4].

5. Fagron

Specializing in pharmaceutical compounding materials, Fagron supplies Tetracaine Hydrochloride for custom formulations. They cater primarily to compounding pharmacies and specialty pharmacies, emphasizing rapid supply and high-quality standards complying with pharmaceutical regulations [5].


Regional and Market-Specific Suppliers

North America

Apart from major global manufacturers, regional suppliers include Acros Organics and TCI Chemicals, providing pharmaceutical-grade Tetracaine Hydrochloride for research and manufacturing.

Europe

European suppliers largely mirror the offerings of Merck KGaA and Sandoz, with additional regional producers like BG Chemical and LTS Lohmann Therapy Systems offering specialty compounds.

Asia-Pacific

In the Asia-Pacific region, China dominates as the primary manufacturing hub with companies like Hainan Zhonghe Pharmaceutical and Shenzhen International Pharmaceutical producing Tetracaine Hydrochloride for domestic and export markets.


Market Dynamics and Supply Chain Considerations

Regulatory Compliance

Suppliers must comply with stringent regulatory standards such as the U.S. FDA, EMA (European Medicines Agency), and China’s NMPA. These compliance requirements impact manufacturing processes, quality control, and distribution logistics.

Raw Material Sourcing

The synthesis of Tetracaine Hydrochloride relies on precursors like benzoic acid derivatives and amines, sourced globally. Disruptions in raw material supplies, whether due to geopolitical issues or trade restrictions, can influence the availability of final products.

Manufacturing Capacity and Scalability

Major suppliers invest heavily in capacity expansion to meet surging demand, especially during global health crises. Manufacturing scalability remains a critical factor, influencing supply stability.

Pricing and Competitive Landscape

The price of Tetracaine Hydrochloride varies depending on purity standards, volume, and regional regulations. Competition among global suppliers continues to drive pricing efficiencies without compromising quality.


Future Outlook and Supply Chain Risks

The pharmaceutical industry is progressively adopting a diversified supplier strategy to mitigate risks associated with geopolitical tensions, supply chain disruptions, and regulatory changes. Suppliers investing in R&D can expand product portfolios to include alternative formulations or derivatives, ensuring continuity of supply.

The increasing demand for ophthalmological and dental procedures globally will sustain the demand for Tetracaine Hydrochloride. Regulatory agencies' emphasis on quality and safety standards further consolidates the position of established, compliant manufacturers.


Key Takeaways

  • Major global suppliers include Sigma-Aldrich (Merck), Jiangsu Hengrui, Sandoz, and Merck KGaA, with regional producers catering specifically to local markets.
  • Supply chain stability depends on strict regulatory adherence, raw material sourcing, manufacturing capacity, and geopolitical stability.
  • Diversification of suppliers and investment in scalable manufacturing facilities are vital for managing risks.
  • The global increase in ophthalmic and dental procedures guarantees ongoing demand, emphasizing the importance of reliable suppliers.
  • Stakeholders should prioritize suppliers with proven regulatory compliance, high-quality standards, and resilient logistics capabilities for uninterrupted supply.

FAQs

1. What are the primary applications of Tetracaine Hydrochloride?
Tetracaine Hydrochloride is mainly used for topical anesthesia in ophthalmic surgeries, dental procedures, and local infiltration anesthesia.

2. Which regions dominate the supply of Tetracaine Hydrochloride?
North America, Europe, and Asia-Pacific are the primary regions where manufacturing and supply are concentrated, with China being a significant production hub.

3. Are there any notable regulatory challenges for suppliers?
Yes, suppliers must adhere to strict standards set by agencies such as the FDA, EMA, and NMPA; non-compliance can disrupt supply chains and restrict market access.

4. How do raw material availability impact the Tetracaine Hydrochloride supply?
Disruptions in sourcing precursor chemicals can delay production, impact costs, and result in shortages or quality issues.

5. What should healthcare providers consider when selecting a Tetracaine Hydrochloride supplier?
Providers should assess supplier regulatory compliance, product purity, manufacturing capacity, quality certifications, and logistical reliability.


References

[1] Sigma-Aldrich Product Information. (2023). Tetracaine Hydrochloride. Merck Group.
[2] Jiangsu Hengrui Medicine Co., Ltd. Annual Report (2022).
[3] Merck KGaA Official Website. Product Catalog.
[4] Sandoz Official Website. Product Portfolio.
[5] Fagron. Pharmaceutical Raw Materials Catalog (2022).


Disclaimer: This analysis is for informational purposes and reflects publicly available data up to 2023. Stakeholders should perform due diligence before engaging with suppliers.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.